Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vornorexant - Taisho Pharmaceutical

Next Previous
Drug Profile

Vornorexant - Taisho Pharmaceutical

Alternative Names: ORN-0829; TS-142

Latest Information Update: 28 Mar 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Taisho Pharmaceutical
  • Class Fluorinated hydrocarbons; Oxazines; Pyrazoles; Pyridines; Sleep disorder therapies; Small molecules; Triazoles
  • Mechanism of Action Orexin receptor type 1 antagonists; Orexin receptor type 2 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Insomnia
  • No development reported Sleep apnoea syndrome

Most Recent Events

  • 28 Mar 2024 No recent reports of development identified for phase-I development in Sleep-apnoea-syndrome(In the elderly, In adults) in Japan (PO, Tablet)
  • 07 Mar 2024 Taisho Pharmaceutical completes a phase III trial for Insomnia in Japan (PO, Tablets) (NCT05461352)
  • 08 Dec 2023 Taisho Pharmaceutical completes a phase I pharmacokinetic trial (In volunteers) in Japan (PO) (NCT05624944)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top